Stage IV Pleural Malignant Mesothelioma AJCC v7
2 clinical trials · Condition
◉ Watch Stage IV Pleural Malignant Mesothelioma AJCC v7
| Record | Firm | Date |
|---|---|---|
| Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors (NCT03074513) | M.D. Anderson Cancer Center | 2017-03-03 |
| Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma (NCT02408016) | Fred Hutchinson Cancer Center | 2015-05-22 |
Track Stage IV Pleural Malignant Mesothelioma AJCC v7 automatically
Every clearance here is in the API, with alerts when new ones post.